共查询到20条相似文献,搜索用时 15 毫秒
1.
Shenghua Zhou Anna M. Cerny An Zacharia Katherine A. Fitzgerald Evelyn A. Kurt-Jones Robert W. Finberg 《Journal of virology》2010,84(18):9452-9462
Type I interferons (IFNs) play a critical role in the host defense against viruses. Lymphocytic choriomeningitis virus (LCMV) infection induces robust type I IFN production in its natural host, the mouse. However, the mechanisms underlying the induction of type I IFNs in response to LCMV infection have not yet been clearly defined. In the present study, we demonstrate that IRF7 is required for both the early phase (day 1 postinfection) and the late phase (day 2 postinfection) of the type I IFN response to LCMV, and melanoma differentiation-associated gene 5 (MDA5)/mitochondrial antiviral signaling protein (MAVS) signaling is crucial for the late phase of the type I IFN response to LCMV. We further demonstrate that LCMV genomic RNA itself (without other LCMV components) is able to induce type I IFN responses in various cell types by activation of the RNA helicases retinoic acid-inducible gene I (RIG-I) and MDA5. We also show that expression of the LCMV nucleoprotein (NP) inhibits the type I IFN response induced by LCMV RNA and other RIG-I/MDA5 ligands. These virus-host interactions may play important roles in the pathogeneses of LCMV and other human arenavirus diseases.Type I interferons (IFNs), namely, alpha interferon (IFN-α) and IFN-β, are not only essential for host innate defense against viral pathogens but also critically modulate the development of virus-specific adaptive immune responses (6, 8, 28, 30, 36, 50, 61). The importance of type I IFNs in host defense has been demonstrated by studying mice deficient in the type I IFN receptor, which are highly susceptible to most viral pathogens (2, 47, 62).Recent studies have suggested that the production of type I IFNs is controlled by different innate pattern recognition receptors (PRRs) (19, 32, 55, 60). There are three major classes of PRRs, including Toll-like receptors (TLRs) (3, 40), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) (25, 48, 51), and nucleotide oligomerization domain (NOD)-like receptors (9, 22). TLRs are a group of transmembrane proteins expressed on either cell surfaces or endosomal compartments. RLRs localize in the cytosol. Both TLRs and RLRs are involved in detecting viral pathogens and controlling the production of type I IFNs (52, 60). In particular, the endosome-localized TLRs (TLR3, TLR7/8, and TLR9) play important roles in detecting virus-derived double-stranded RNA (dsRNA), single-stranded RNA (ssRNA), and DNA-containing unmethylated CpG motifs, respectively. In contrast, RIG-I detects virus-derived ssRNA with 5′-triphosphates (5′-PPPs) or short dsRNA (<1 kb), whereas melanoma differentiation-associated gene 5 (MDA5) is responsible for recognizing virus-derived long dsRNA as well as a synthetic mimic of viral dsRNA poly(I):poly(C) [poly(I·C)] (24, 60). Recognition of viral pathogen-associated molecular patterns (PAMPs) ultimately leads to the activation and nuclear translocation of interferon regulatory factors (IRFs) and nuclear factor κB (NF-κB), which, in turn, switches on a cascade of genes controlling the production of both type I IFNs and other proinflammatory cytokines (10, 11, 60).Lymphocytic choriomeningitis virus (LCMV) infection in its natural host, the mouse, is an excellent system to study the impact of virus-host interactions on viral pathogenesis and to address important issues related to human viral diseases (1, 45, 49, 67). LCMV infection induces type I IFNs as well as other proinflammatory chemokines and cytokines (6, 41). Our previous studies have demonstrated that TLR2, TLR6, and CD14 are involved in LCMV-induced proinflammatory chemokines and cytokines (66). The mechanism by which LCMV induces type I IFN responses, however, has not been clearly defined (7, 8, 31, 44). The role of the helicase family members RIG-I and MDA5 in virus-induced type I IFN responses has been recently established. RIG-I has been found to be critical in controlling the production of type I IFN in response to a number of RNA viruses, including influenza virus, rabies virus, Hantaan virus, vesicular stomatitis virus (VSV), Sendai virus (SeV), etc. In contrast, MDA5 is required for responses to picornaviruses (15, 25, 63).In the present study, we demonstrated that LCMV genomic RNA strongly activates type I IFNs through a RIG-I/MDA5-dependent signaling pathway. Our present study further demonstrated that the LCMV nucleoprotein (NP) blocks LCMV RNA- and other viral ligand-induced type I IFN responses. 相似文献
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Subbiah Elankumaran Vrushali Chavan Dan Qiao Raghunath Shobana Gopakumar Moorkanat Moanaro Biswas Siba K. Samal 《Journal of virology》2010,84(8):3835-3844
Newcastle disease virus (NDV), an avian paramyxovirus, is tumor selective and intrinsically oncolytic because of its potent ability to induce apoptosis. Several studies have demonstrated that NDV is selectively cytotoxic to tumor cells but not normal cells due to defects in the interferon (IFN) antiviral responses of tumor cells. Many naturally occurring strains of NDV have an intact IFN-antagonistic function and can still replicate in normal human cells. To avoid potential toxicity issues with NDV, especially in cancer patients with immunosuppression, safe NDV-oncolytic vectors are needed. We compared the cell killing abilities of (i) a recombinant NDV (rNDV) strain, Beaudette C, containing an IFN-antagonistic, wild-type V protein (rBC), (ii) an isogenic recombinant virus with a mutant V protein (rBC-Edit virus) that induces increased IFN in infected cells and whose replication is restricted in normal human cells, and (iii) a recombinant LaSota virus with a virulent F protein cleavage site that is as interferon sensitive as rBC-Edit virus (LaSota V.F. virus). Our results indicated that the tumor-selective replication of rNDV is determined by the differential regulation of IFN-α and downstream antiviral genes induced by IFN-α, especially through the IRF-7 pathway. In a nude mouse model of human fibrosarcoma, we show that the IFN-sensitive NDV variants are as effective as IFN-resistant rBC virus in clearing the tumor burden. In addition, mice treated with rNDV exhibited no signs of toxicity to the viruses. These findings indicate that augmentation of innate immune responses by NDV results in selective oncolysis and offer a novel and safe virotherapy platform.Several naturally occurring or engineered oncolytic viruses are emerging as novel tools for selective growth in and killing of a variety of tumor cells (1, 21, 34, 41). It has been consistently reported that during tumor evolution, diminished interferon (IFN) responsiveness coevolves as a frequent genetic defect (4, 31, 32, 41). Any defects in responsiveness to interferon will afford permissiveness of tumors for replication of oncolytic viruses by blunting the antiviral innate immune system. Thus, it was suggested that oncolytic viruses could be engineered to induce strong IFN response and/or to be defective in antagonizing the IFN signaling. This would result in virus replication in tumor cells with IFN defects but in reduced or crippled virus replication in normal cells, with the absence of toxicity (42). A variety of oncolytic viruses have been engineered to exploit tumor-specific genetic defects (3, 12, 24, 42, 46) and shown to be potent oncolytic agents.Newcastle disease virus (NDV), an avian paramyxovirus, is a promising broad-spectrum oncolytic agent (27, 29, 30, 37). Nonengineered, naturally occurring strains of NDV such as 73-T (6), MTH68 (7), PV701 (28, 35), and NDV-HUJ (11) have been successfully employed in several clinical studies for tumor regression. NDV is inherently oncolytic and tumor selective, sparing normal cells (9, 15, 37). The tumor selectivity of NDV is considered to be due to a defective IFN response in tumor cells (10, 23, 37). NDV is a strong inducer of type I IFN in many types of cells (18). In normal cells, a robust IFN-mediated antiviral response limits the replication of NDV (9, 23). This known sensitivity of NDV to cellular antiviral mechanisms affords a wide safety margin for its use in humans.Recent studies have indicated that improved therapeutic vectors of NDV could be engineered through reverse genetics for enhanced oncolytic efficacy from an increased anti-tumor response and interleukin 2 (IL-2) receptor-mediated targeting (5, 9, 44, 46). Therefore, we reasoned that recombinant NDVs (rNDVs) that are susceptible to cellular innate immune responses would be safer and more effective oncolytic agents. Even though NDV is an avian virus and induces a strong IFN response in normal human cells, it still expresses IFN-antagonizing activity. Ablation of the expression of V protein, which is responsible for this anti-IFN activity, may further reduce the ability of NDV to infect and kill normal human cells without affecting tumor cell infection and lysis. Here, we describe the relative oncolytic efficacies of three rNDV strains differing in IFN antagonism. The rNDV variants with an IFN-sensitive phenotype had parallel therapeutic efficacies in xenotransplanted human fibrosarcoma cells in a nude mouse model and offer great potential as recombinant vectors in therapy of human malignancies. 相似文献
12.
13.
14.
Kester Haye Svetlana Burmakina Thomas Moran Adolfo García-Sastre Ana Fernandez-Sesma 《Journal of virology》2009,83(13):6849-6862
15.
16.
17.
18.
Kouji Kobiyama Fumihiko Takeshita Nao Jounai Asako Sakaue-Sawano Atsushi Miyawaki Ken J. Ishii Taro Kawai Shin Sasaki Hisashi Hirano Norihisa Ishii Kenji Okuda Koichi Suzuki 《Journal of virology》2010,84(2):822-832
Fragments of double-stranded DNA (dsDNA) forming a right-handed helical structure (B-DNA) stimulate cells to produce type I interferons (IFNs). While an adaptor molecule, IFN-β promoter stimulator 1 (IPS-1), mediates dsDNA-induced cellular signaling in human cells, the underlying molecular mechanism is not fully understood. Here, we demonstrate that the extrachromosomal histone H2B mediates innate antiviral immune responses in human cells. H2B physically interacts with IPS-1 through the association with a newly identified adaptor, CIAO (COOH-terminal importin 9-related adaptor organizing histone H2B and IPS-1), to transmit the cellular signaling for dsDNA but not immunostimulatory RNA. Extrachromosomal histone H2B was biologically crucial for cell-autonomous responses to protect against multiplication of DNA viruses but not an RNA virus. Thus, the present findings provide evidence indicating that the extrachromosomal histone H2B is engaged in the signaling pathway initiated by dsDNA to trigger antiviral innate immune responses.Fragments of nucleic acids derived from either infectious agents or host cells activate cell-autonomous responses to inhibit multiplication of certain viruses by inducing type I interferon (IFN) production (5). Such effects are more evident when double-stranded DNA (dsDNA) is transduced into the intracellular compartment by use of a transfection agent or electroporation method, suggesting that the DNA sensing system recognizes aberrant DNA fragments inside the cell (6, 21, 23). dsDNA forming a right-handed helical structure, i.e., B-DNA, has a greater ability to induce type I IFNs than Z-DNA, which has a left-handed zig-zag structure (6). dsDNA activates type I IFN production in a wide variety of cell types, including immune cells, such as dendritic cells and macrophages, and nonimmune cells, such as fibroblasts, epithelial cells, and thyroid cells (6, 23). Such effects of dsDNA were corroborated by the observation in mice deficient for DNase II, in which intracellular accumulation of undegraded DNA fragments resulted in hyperproduction of IFN-β, dysregulation of erythropoiesis, and symptoms resembling rheumatoid arthritis (12, 28). The loss-of-function mutation of the DNase I gene has been found in patients with systemic lupus erythematosus (SLE) and, in fact, DNase I−/− mice manifest SLE-like symptoms with anti-DNA antibody (Ab) production (18, 27).The immunostimulatory property of dsDNA is quite similar to that of immunostimulatory RNA (isRNA), such as dsRNA and 5′-triphosphate RNA (2, 6). Indeed, the signaling pathways engaged by dsDNA in part are shared with those for isRNA. Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) directly associate with isRNA and trigger signaling, while it has been demonstrated that RIG-I does not directly interact with dsDNA but mediates its signaling in a human hepatoma cell line, Huh7 (2). IFN-β promoter stimulator 1 (IPS-1, also known as mitochondrial antiviral signaling), mediates the downstream signaling induced by dsDNA or isRNA in humans, while IPS-1 solely mediates isRNA but not dsDNA signaling in mice (2, 6, 15, 22). In contrast, TANK-binding kinase 1 (TBK1) and inducible IκB kinase (IKKi) are essential for dsDNA- or isRNA-induced type I IFN production in both humans and mice (2, 6). While examining distinct molecules involved in dsDNA-mediated but not isRNA-mediated upstream signaling, Z-DNA binding protein 1 (ZBP1, also known as DNA-dependent activator of IFN regulatory factors [DAI]) was identified as a candidate cytosolic DNA sensor, at least in a mouse connective tissue cell line, L929, although its in vivo role was dispensable (7, 24, 26). Recently, a PYHIN family member, Absent in melanoma 2 (AIM2) protein, was shown to associate with an inflammasome signaling adaptor, apoptosis-associated speck-like protein containing a CARD (ASC), and to play a critical role for caspase 1 activation and interleukin-1β (IL-1β) secretion in response to dsDNA (1, 3, 4, 20).In the present study, we show that extrachromosomal histone H2B is responsible for the dsDNA-induced type I IFN production in human cells and for the innate immune response to DNA virus infection. 相似文献
19.